Research

Our goal can be summarized with the following sentence:

We identify and optimize new leads for the interaction with interesting targets.

Using a combination of computational tecniques and biochemical assays, we screen and design new potential leads. Then we optimize the obtained leads in collaboration with organic chemists and pharmacologists.

MAGL Screening Platform

Current projects:

ERB
FYN
consensus
LDH
MAGL
target

glut1
CB

Presentazione standard di PowerPoint